登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688607 证券简称：康众医疗 公告编号：2026-004 江苏康众数字医疗科技股份有限公司 2026年第一次临时股东会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 本次会议是否有被否决议案：无 一、会议召开和出席情况 （一）股东会召开的时间：2026年1月27日 （二）股东会召开的地点：苏州工业园区星湖街218号生物纳米园B3楼501室公司会议室 （三）出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及其持有表决权数量的情 况： ■ 注：公司具有表决权股票总数已剔除公司回购专户无表决权股票数量737,722股。 （四）表决方式是否符合《公司法》及公司章程的规定，股东会主持情况等。 1、本次股东会采用现场投票和网络投票相结合的方式进行表决； 2、本次会议由公司董事会召集，董事长JIANQIANGLIU（刘建强）先生主持； 3、本次会议的召集召开程序、表决方式和表决程序符合《公司法》及《公司章程》的规定，会议合法 有效。 ...

Core Viewpoint - The development of new quality productivity is an inherent requirement and important focus for promoting high-quality development in Chaoyang District, leveraging technological innovation to build a modern industrial system and stimulate new regional development momentum [1] Group 1: Industry Development - Chaoyang District has implemented action plans for Internet 3.0 (metaverse), digital healthcare, artificial intelligence, data elements, and intelligent robotics, enhancing the development capabilities of the digital economy core area [2] - The district has established a robust cluster of leading industries, with over 700 artificial intelligence companies and more than 1,000 enterprises in the industrial internet sector, supported by major internet platforms like Alibaba and Meituan [3][4] - The digital economy computing power center has been completed, achieving a computing capacity of 1000 PFlops, and the first AIGC audiovisual industry innovation center has been established [3] Group 2: Technology Innovation and Transformation - Chaoyang District is enhancing its technology innovation capabilities by establishing a technology innovation development belt and launching various innovation centers, resulting in over 200 technology innovation enterprises [7] - The district has invested over 1.6 billion yuan in technology industry funding during the 14th Five-Year Plan period, supporting more than 2,500 enterprises [9] - A financial service team comprising nearly 200 partners has been formed to provide credit support exceeding 12 billion yuan for technology-based SMEs [9] Group 3: Application and Internationalization - The district is actively constructing diverse application scenarios, including the establishment of the Internet 3.0 application scenario research institute and various metaverse benchmark application cases [13] - Chaoyang has been recognized as the first "International Technology Organization Headquarters Cluster," attracting 15 international technology organizations and hosting over 100 international exchange activities [14] - The district has established international technology service stations in 12 countries and regions, covering over 20 countries [13] Group 4: Reform and Innovation - Chaoyang District is enhancing its technology park construction and reforming its management structure to support sustainable development in technology innovation and new quality productivity [16][18] - The district is focusing on improving the quality of park development, with plans to integrate large areas into national and municipal high-tech zones [19] - The district aims to build a highland for the transformation of cutting-edge technology achievements and international cooperation by 2025 [21] Group 5: Performance Metrics - By the first ten months of 2025, the combined GDP contribution of information services, technology services, and industrial added value reached 27.7%, an increase of 6.3 percentage points from the end of the 13th Five-Year Plan [22] - The district has established 23 specialized industrial parks, with 9 recognized by municipal departments, and has a significant number of national high-tech enterprises and specialized small and medium-sized enterprises [22]

Core Insights - Novartis announced a significant collaboration at the 2026 World Economic Forum, focusing on a data-driven cardiovascular disease prevention project called CARDIO4Cities, in partnership with the Brunei Ministry of Health and EVYD, a subsidiary of Yidu Tech [1] - The project aims to leverage the BruHealth digital health platform to identify high-risk populations early and implement precise interventions, thereby reducing the risk of cardiovascular diseases and improving health management in Brunei [1] Group 1: Project Overview - The CARDIO4Cities project is designed to address the high burden of cardiovascular diseases, which are a leading cause of death globally, accounting for over 70% of deaths [8] - In Brunei, cardiovascular diseases are the primary cause of mortality, putting pressure on the public health system [8] - The project will utilize AI to categorize cardiovascular disease risk levels among the population and provide tailored management plans [8][9] Group 2: Technological and Systemic Innovations - The initiative represents a strategic national-level practice aimed at transforming public health systems from reactive to proactive, and from fragmented services to systematic governance [8] - The BruHealth platform, initially developed for tracking infectious diseases during the pandemic, has evolved into a comprehensive digital infrastructure covering over 85% of Brunei's population [10] - The collaboration will enhance data integration, analysis, and technical support for the project, with EVYD playing a key role [10] Group 3: Global Implications - The CARDIO4Cities project has been implemented in over 40 cities worldwide, with previous implementations showing potential to increase blood pressure control rates by 3 to 6 times and reduce stroke incidence by up to 13% [10] - This collaboration not only provides a new solution for cardiovascular disease prevention in Brunei but also serves as a reference model for global non-communicable disease management [11] - The project is expected to significantly improve public health services in Brunei and reduce the health and social burden of cardiovascular diseases [11]

Group 1 - The insurance sector saw significant gains, with China Life (02628) up 3.81%, China Pacific Insurance (02601) up 2.31%, and Ping An (02318) up 1.17%. Notably, major insurance companies reported a doubling in premium income through bancassurance channels as of January 8, 2026 [1] - The commercial aerospace sector experienced a notable decline, with companies like JunDa Co. (02865) down 7.19% and Asia Pacific Satellite (01045) down 5.94%. This follows a period of intense adjustments and risk warnings from several listed companies in the sector [1] - The real estate sector showed active performance, with companies like R&F Properties (02777) up 4% and Greentown China (03900) up 5.79%. Data from the National Bureau of Statistics indicated a 0.3% month-on-month decline in new residential sales prices in first-tier cities for December 2025, a slight improvement from the previous month [2] Group 2 - HuShang Ayi (02589) reported an expected net profit of 495 million to 525 million RMB for 2025, reflecting a year-on-year growth of 50% to 60% [3] - Yi Communications Group (08031) saw a surge of over 70% upon resuming trading, with a current increase of 53.85%. The company announced a share acquisition deal involving 210 million shares at a price of 0.276 HKD per share, which is a 15.08% discount from the pre-suspension closing price [3] - Guorui Life (00108) experienced an increase of over 11% after announcing a deal to acquire 78.29% of Chunyu Doctor for 269 million RMB, marking its entry into the digital healthcare sector [4]

Core Viewpoint - Cleveland Clinic Abu Dhabi has signed a strategic partnership agreement with DAWI, a leading digital healthcare platform in Kuwait, to promote cross-border high-end medical services [1] Group 1: Partnership Details - The collaboration aims to integrate top international clinical resources with a digital healthcare platform [1] - DAWI will serve as the exclusive digital partner for the executive health management program in the Kuwaiti market [1] Group 2: Future Prospects - The initial phase will focus on the executive health management program, with potential for expanding into more specialized fields in the future [1]

Core Viewpoint - The article emphasizes the role of Shenwan Hongyuan Securities in supporting specialized and innovative enterprises in the capital market, highlighting its commitment to becoming a leading modern investment bank through enhanced professional capabilities and services [1][8]. Group 1: Value Discovery Capability - Value discovery is identified as the first step in optimizing resource allocation in the capital market, necessitating higher professional discernment and value extraction capabilities from securities firms [1][2]. - The company aims to cultivate and select more hard technology and quality enterprises during the 14th Five-Year Plan period, enhancing market inclusivity and adaptability [2]. Group 2: Product Creation Capability - The enhancement of product creation capabilities is crucial for better serving residents' wealth management needs, addressing challenges such as insufficient product supply and lack of stable long-term returns [3][4]. - The company is focused on providing diverse, high-quality products and adopting a buyer-oriented investment advisory service model to meet investor demands for stable returns [3][4]. Group 3: Risk Pricing Capability - Improving risk pricing capabilities is essential for enhancing China's capital market's influence and ensuring financial security amid the rise of new economic sectors [5][6]. - The company is tasked with innovating valuation methodologies to adapt to new technologies and business models, thereby reducing investor cognitive risks [5][6]. Group 4: Global Allocation Capability - The company recognizes the need to enhance its international business capabilities to match China's economic scale and openness, facilitating foreign investment in China [6]. - It aims to establish a comprehensive cross-border financial service system to support both inbound and outbound investments [6]. Group 5: Reputation Management Capability - Reputation management is deemed fundamental for the survival and development of the financial industry, with a focus on embedding compliance and professionalism into the company's culture [7]. - The company is committed to maintaining high-quality professional output and actively contributing to market stability and investor confidence [7][8].

Core Insights - North China Resources (00618) announced a collaboration between ResoHealth and Trivitron Healthcare to launch Trivitron Digital AI, aimed at transforming healthcare services in India's tier-2 and tier-3 cities [1] - The initiative addresses the urgent need for advanced digital infrastructure in India, enhancing patient care, data management, and doctor-patient interaction [1][2] - Trivitron Digital AI will provide integrated cloud solutions to bridge the digital divide, improving operational efficiency and enabling patient-centered AI-driven diagnostics [1] Summary by Sections Digital Health Initiative - Trivitron Digital AI combines the strengths of Trivitron Healthcare and ResoHealth to offer innovative solutions that enhance interoperability and operational efficiency in healthcare systems [1][2] - The platform includes a comprehensive toolkit such as Laboratory Information Management Systems (LIS), Web-PACS for medical imaging, and Personal Health Records (PHR) to facilitate patient self-management [1] Leadership and Vision - The initiative will be led by Dr. G.S.K. Velu and Dr. Vas Metupalle from Trivitron Healthcare, emphasizing the importance of transitioning to an integrated digital ecosystem in healthcare [2] - Dr. Velu highlighted the goal of providing high-quality, transparent healthcare services to medium-sized hospitals and diagnostic networks, regardless of their location [2] Global Expansion and Impact - Trivitron Digital AI plans to expand beyond India to regions such as Africa, the Middle East, and Southeast Asia, addressing similar healthcare challenges and enabling local institutions to benefit from interconnected healthcare solutions [2] - The launch marks a significant step towards global digital healthcare inclusivity, redefining service models to make quality healthcare more accessible [3]

Core Insights - North China Resources (00618) announced a strategic partnership between ResoHealth and Trivitron Healthcare to launch Trivitron Digital AI, aimed at revolutionizing healthcare services in India's tier-2 and tier-3 cities [1][2] - The initiative addresses the urgent need for advanced digital infrastructure in India, providing integrated cloud solutions to enhance operational efficiency and patient-centered AI diagnostics [1][2] - Trivitron Digital AI will also expand to Africa, the Middle East, and Southeast Asia to tackle similar healthcare challenges [2] Group 1 - The collaboration focuses on creating innovative solutions that transform hospital operations in patient care, data management, and doctor-patient interactions [1] - Trivitron Digital AI includes a comprehensive toolkit such as Laboratory Information Management Systems (LIS) and Web-PACS for improved clinical collaboration [1][2] - The platform's development adheres to global standards (HL7, FHIR, DICOM, HIPAA, GDPR, ABHA) and requires minimal additional infrastructure, making it suitable for regions with lower digitalization levels [2] Group 2 - The initiative is led by Dr. G.S.K. Velu and Dr. Vas Metupalle, emphasizing the importance of transitioning to an integrated digital ecosystem in healthcare [2] - The platform aims to empower patients and ensure seamless management of healthcare information [2] - The launch marks a significant step towards making global digital healthcare more inclusive and accessible [3]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 就 因 本 公 告 全部或任何部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責 任。 Peking University Resources (Holdings) Company Limited 北大資源（控股）有限公司 （於百慕達註冊成立之有限公司） （股份代號：00618） 自願性公告 推 出TRIVITRON DIGITAL AI 本 公 告 由 北 大 資 源（控 股）有 限 公 司（「本公司」，連 同 其 附 屬 公 司 統 稱「本集團」） 自 願 作 出。 與Trivitron Healthcare合作推出Trivitron Digital AI Dr. Vas Metupalle詳 細 說 明 了 該 平 台 聚 焦 患 者 賦 能 與 使 用 便 捷 性 的 核 心 理 念，致 力 於 實 現 醫 療 健 康 資 訊 的 無 縫 管 理。 Trivitron Digital AI融合了Trivitron Health ...

Core Viewpoint - The company, Brainstorm Aurora-B (06681), has signed significant business cooperation agreements with Peking University Sixth Hospital and Shandong Mental Health Center to advance the research and commercialization of digital therapies for mental health [1][4]. Group 1: Business Developments - The company’s stock price increased by 8.46%, currently trading at 7.82 HKD with a transaction volume of 149 million HKD [1][4]. - The collaboration with Peking University Sixth Hospital and Shandong Mental Health Center aims to enhance the development of mental health digital therapy products [1][4]. - The company has also received approval to establish the "Precision Intelligent Diagnosis and Treatment Innovation and Transformation Key Laboratory for Mental Disorders" in collaboration with Peking University Sixth Hospital and the National Engineering Research Center for Software Engineering [1][4]. Group 2: Strategic Partnerships - The company has formed a close commercial partnership with Beijing Anding Hospital, a top-tier mental health hospital and national center for mental disorders, to promote the clinical application of mental health digital therapy products [1][4]. - The recent partnerships expand the company's network within core mental health specialty hospitals across the country, creating a comprehensive commercial implementation network from national flagship centers to regional hubs and key specialty hospitals [1][4].